These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 9040990

  • 1. Predictive quantitative structure-activity relationships (QSAR) analysis of beta 3-adrenergic ligands.
    Blin N, Federici C, Koscielniak T, Strosberg AD.
    Drug Des Discov; 1995 Apr; 12(4):297-311. PubMed ID: 9040990
    [Abstract] [Full Text] [Related]

  • 2. Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
    Blin N, Camoin L, Maigret B, Strosberg AD.
    Mol Pharmacol; 1993 Dec; 44(6):1094-104. PubMed ID: 7903415
    [Abstract] [Full Text] [Related]

  • 3. Potent and selective human beta(3)-adrenergic receptor antagonists.
    Candelore MR, Deng L, Tota L, Guan XM, Amend A, Liu Y, Newbold R, Cascieri MA, Weber AE.
    J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
    [Abstract] [Full Text] [Related]

  • 4. Agonist interactions with chimeric and mutant beta1- and beta3-adrenergic receptors: involvement of the seventh transmembrane region in conferring subtype specificity.
    Granneman JG, Lahners KN, Zhai Y.
    Mol Pharmacol; 1998 May; 53(5):856-61. PubMed ID: 9584211
    [Abstract] [Full Text] [Related]

  • 5. QSAR analysis of thiazole benzenesulfonamide substituted 3-pyridylethanolamines as beta3-adrenergic receptor agonist.
    Hanumantharao P, Sambasivarao SV, Soni LK, Gupta AK, Kaskhedikar SG.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3167-73. PubMed ID: 15908203
    [Abstract] [Full Text] [Related]

  • 6. QSAR study of imidazoline antihypertensive drugs.
    Nikolic K, Filipic S, Agbaba D.
    Bioorg Med Chem; 2008 Aug 01; 16(15):7134-40. PubMed ID: 18621536
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.
    Leonardi A, Motta G, Boi C, Testa R, Poggesi E, De Benedetti PG, Menziani MC.
    J Med Chem; 1999 Feb 11; 42(3):427-37. PubMed ID: 9986714
    [Abstract] [Full Text] [Related]

  • 8. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE, Tseng T, Brusniak MY, Ginsburg B, Pearlman RS, Teeter M, DuRand C, Starr S, Neve KA.
    J Med Chem; 1998 Oct 22; 41(22):4385-99. PubMed ID: 9784114
    [Abstract] [Full Text] [Related]

  • 9. QSAR study of selective ligands for the thyroid hormone receptor beta.
    Liu H, Gramatica P.
    Bioorg Med Chem; 2007 Aug 01; 15(15):5251-61. PubMed ID: 17524652
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular orbital studies on the mechanism of drug-receptor interaction. 5. Molecular reactivity and receptor affinity of beta-agonist adrenergic drugs.
    Macchia B, Martinelli A.
    Drug Des Deliv; 1988 May 01; 2(4):273-86. PubMed ID: 2908224
    [Abstract] [Full Text] [Related]

  • 16. Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV.
    Nakajima Y, Imanishi M, Itou S, Hamashima H, Tomishima Y, Washizuka K, Sakurai M, Matsui S, Imamura E, Ueshima K, Yamamoto T, Yamamoto N, Ishikawa H, Nakano K, Unami N, Hamada K, Hattori K.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5037-40. PubMed ID: 18752946
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and beta-adrenergic activity of new completely aliphatic 3-(methyleneaminoxy)propanolamine derivatives.
    Balsamo A, Gentili D, Lapucci A, Macchia M, Martinelli A, Orlandini E, Ferni G, Pinza M.
    Farmaco; 1994 Dec 15; 49(12):759-66. PubMed ID: 7893332
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G, Butini S, Trotta F, Fattorusso C, Catalanotti B, Aiello F, Gemma S, Nacci V, Novellino E, Stark JA, Cagnotto A, Fumagalli E, Carnovali F, Cervo L, Mennini T.
    J Med Chem; 2003 Aug 28; 46(18):3822-39. PubMed ID: 12930145
    [Abstract] [Full Text] [Related]

  • 19. Application of validated QSAR models of D1 dopaminergic antagonists for database mining.
    Oloff S, Mailman RB, Tropsha A.
    J Med Chem; 2005 Nov 17; 48(23):7322-32. PubMed ID: 16279792
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and bovine beta 3-adrenergic agonistic activities of a novel series of aryloxypropanolamines.
    el Hadri A, Nicolle E, Guillaume MC, Leclerc G, Pietri-Rouxel F, Strosberg AD, Archimbault P.
    Pharmazie; 2001 Jul 17; 56(7):517-22. PubMed ID: 11487967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.